Skip to content

    Punjab Chemicals

    PUNJABCHEM
    Chemicals·5 May 2026
    Management Summary

    Punjab Chemicals delivered a robust performance in Q4 and full-year FY26, achieving record revenue and significant PAT growth, driven by new product contributions and operational efficiencies. Despite geopolitical headwinds causing supply chain disruptions and raw material volatility, the company maintained strong margins and successfully passed on most cost increases. Strategic CAPEX plans for debottlenecking and greenfield expansion are underway to support future growth and product diversification.

    Highlights

    5
    • Full-year FY26 revenue of ₹1,029.8 crores, up 14.4% YoY, achieving highest ever revenue.

    • Q4 FY26 gross margins at 49.4%, up 580 bps YoY, and EBITDA at ₹27.5 crores, up 7.9% YoY.

    • Full-year FY26 PAT grew significantly by 64.3% to ₹64 crores.

    • New products contributed 14% to the top line in FY26, growing 16% YoY, with an absolute increase of 32-33% from FY25.

    • Strong pipeline of new products and ongoing CAPEX initiatives to capture incremental demand and align with 'Make in India' theme.

    Concerns

    4
    • Exports saw a marginal decline of 4.8% in Q4 FY26.

    • Geopolitical situation causing supply chain disruptions, sudden price changes, and recalibration of demand cycle.

    • Potential market resistance if price increases go beyond a certain level, impacting pass-on ability.

    • One acquisition opportunity did not materialize due to due diligence issues.

    Key financials

    Metrics

    6

    Periods

    2

    Q4 FY26

    2
    • Revenue
      ₹208.6 Cr
      YoY+3.1%
    • Gross Margin
      49.4%

    FY26

    4
    • Revenue
      ₹1,029.8 Cr
      YoY+14.4%
    • EBITDA
      ₹118.1 Cr
      YoY+19.1%
    • EBITDA Margin
      11.5%
    • PAT
      ₹64 Cr
      YoY+64.3%

    Segment breakdown

    Agrochemical division
    81% Capacity Utilization
    Performance Chemical division
    65% Capacity Utilization
    Industrial Chemical division
    90% Capacity Utilization
    List

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    ₹105 crores

    Debt

    Debt disclosed

    M&A

    Undisclosed

    acquisition · abandoned

    Guidance & targets

    12
    CategoryTargetPriority
    Revenue
    Revenue Growth
    15-20%
    High
    Revenue
    Total Revenue
    ₹1400-1500 crores
    High
    Revenue
    Revenue Growth (FY27/FY28)
    20%
    Medium
    Profitability
    EBITDA Margin
    15%
    High
    Profitability
    EBITDA Margin (New Products)
    15-16%
    High
    Profitability
    EBITDA Margin (New Products)
    18%
    High
    New Products
    New Product Revenue Growth
    25%
    High
    CDMO
    Additional Sales from New Products
    ₹150-200 crores
    High
    ROCE
    ROCE from New Business Investment
    At least 3x
    Medium
    Industrial Chemicals
    Industrial Chemicals Revenue Growth
    Doubling
    High
    Capex
    Greenfield CAPEX Announcement
    Announcement of site
    High
    Gross Margins
    Gross Margin Improvement
    100 bps each year
    Medium

    Greenfield CAPEX Announcement

    Q2 or Q3 FY27
    Current1-2 sites finalized, but due diligence issues
    TargetAnnouncement of a site

    Why it matters

    Crucial for future growth and capacity expansion beyond existing sites, indicating long-term strategic execution.

    But right now we are very confident as I mentioned that maybe by Q2 or Q3 we definitely will have a site with us which will help in announcing our business because business right now is very robustic.

    How to verify

    capital_allocation.capex.fy_planned

    Risks & concerns

    6
    RiskSeverity

    Global Geopolitical Situation

    Resulted in supply chain disruptions, sudden price changes, and recalibration of demand cycle.Management acknowledged

    high

    Market Resistance to Price Increases

    If prices increase beyond a certain level, there is a resistance in the market.Management acknowledged

    medium

    Raw Material and Logistics Cost Volatility

    Industry is witnessing renewed volatility driven by supply chain disruptions, rising raw material and logistics costs.Management acknowledged

    high

    Chinese Competition

    Chinese competition cannot be whizzed away, it remains intense, though Chinese companies are also increasing prices.Management acknowledged

    medium

    Execution Risk for MoU Commercialization

    Potential delay of a couple of months for commercialization of 3 MoU products in FY27 due to customer trials or geopolitical issues.Management acknowledged

    low

    Inventory Hit Risk

    Precaution taken not to build raw material position unless customer confirmation is received to avoid inventory hit.Management acknowledged

    low

    Q&A highlights

    8

    “year-on-year, we are investing about INR 25 crores to INR 30 crores for asset renewal. So that is the kind of gross block increase on account of asset renewal per year. So, if you take 2 years, it should be around anywhere between INR 55 crores to INR 60 crores. And INR 35 crores to INR 40 crores is on account of capacity addition or any CAPEX related to compliance improvement and also debottlenecking.”

    Clarified the allocation of CAPEX between essential maintenance/renewal and growth-oriented capacity expansion.

    asked by Jainam Ghelani

    2 min read6 chapters

    Detailed Narrative

    01

    Resilient Performance Amidst Geopolitical Headwinds

    Punjab Chemicals demonstrated resilient performance in FY26, achieving its highest-ever revenue from operations at ₹1,029.8 crores, marking a 14.4% year-on-year growth. This was accomplished despite global geopolitical disruptions over the last two months, which led to supply chain disruptions, sudden price changes, and demand recalibration. The company continues to monitor the situation closely, focusing on strengthening core fundamentals and executing its long-term strategy.

    02

    Strong Margin Expansion and Profitability Growth

    The company reported robust profitability, with Q4 FY26 gross margins at 49.4%, an increase of 580 basis points year-on-year. EBITDA for Q4 FY26 stood at ₹27.5 crores, up 7.9% YoY, with EBITDA margins at 13.2%. For the full year FY26, EBITDA was ₹118.1 crores (up 19.1% YoY) with margins of 11.5%, and Profit After Tax (PAT) surged by 64.3% to ₹64 crores, reflecting a solid growth trajectory.

    03

    New Products and Diversified Business Model Driving Growth

    New products played a significant role, contributing approximately 14% to the top line in FY26, growing 16% over the previous year, from ₹108 crores in FY25 to ₹145 crores in FY26. The company's diversified business model across agrochemicals, performance chemicals, and industrial chemicals, coupled with a focus on operational efficiency and product mix optimization, supported stable volume across all products. Management expects new products to grow by 25% over last year in FY27.

    04

    Strategic CAPEX and Greenfield Expansion Plans

    Punjab Chemicals is actively investing in CAPEX initiatives, including debottlenecking and new manufacturing blocks. Annual asset renewal CAPEX is ₹25-30 crores, with an additional ₹35-40 crores for capacity addition, debottlenecking, and compliance. For FY27, a total CAPEX of ₹105-130 crores is planned, including ₹60-80 crores for a new production block. The company is also pursuing Greenfield CAPEX, with an announcement for a new site expected in Q2 or Q3 of the current year.

    05

    Raw Material Sourcing and Price Pass-Through

    The company's dependency on imports, including from China, is about 25%, with the rest sourced domestically. Despite rising raw material and logistics costs due to geopolitical events, the company has largely been able to pass on these price increases to customers. Management noted that while the market has accepted incremental price gains so far, resistance might emerge if prices increase beyond a certain threshold, prompting careful monitoring of the situation.

    06

    CDMO Business and Export Market Focus

    The CDMO business contributed 24-26% to revenue in FY26, with new products expected to bring in an additional ₹150-200 crores in sales over the next two years. The company's export strategy is focused on Europe, Japan, and North America, with industrial chemicals revenue projected to double in the next two years, partly driven by expansion into Southeast Asia. While some export sales were deferred in Q4 FY26, overall relationships remain strong, and commercialization of MoU products is on track for FY27.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.